Life Sciences Industry

Clinical Trial Management

Drivers and Challenges

Leading analysts of the life sciences industry have confirmed three major drivers for the clinical trial area: reduce costs, shorten preparation and manufacturing time, and increase number and complexity of clinical supplies. The prominent target in all strategical activities is to manufacture and deliver trial medication matching the market demands with regard to type, time, place, and price.

Costs — Task-related planning and scheduling features provide for on-time delivery of the required materials to the respective sites. This reduces the required storage capacities as well as waste caused by violence of the tight expiry dates and thus lowers costs.

Time-to-market — Electronic study management, online documentation, and user friendly design provide for decisive relief and an efficiency increase during clinical trial. The seamless integration of the system avoids friction in data transfer, and job-oriented multilingual support eases the execution of cross-cultural studies. Together these factors contribute to accelerated time-to-market.

Regulatory compliance — The genealogical features of this solution deliver reliable evidence of the origin, composition, and handling of any patient kits. This is especially useful to verify the cause of unexpected results in the case of blinded studies, resulting in extra compliance backing